IFPAC® - 2016
30th INTERNATIONAL FORUM AND EXHIBITION
PROCESS ANALYTICAL TECHNOLOGY
(Process Analysis & Control) - IFPAC
Jan. 24-27, 2016
Arlington, VA, (Washington, DC) USA

Process Analytical Technology is one of the most exciting and important advanced technology areas meeting both the current challenges, as well as the future needs of industry. Since 1987, the IFPAC conferences have generated the enthusiastic response that resulted in the creation of this International meeting of manufacturers, researchers and industry users. Process Analytical Technology equipment and services will be on exhibit during the forum.

So please join us...meet with your colleagues...the people who are the foundation of Process Analytical Technology (PAT), Quality by Design (QbD), Process Understanding & Control, and Real-Time Analytics. Come share in discussions, give input and get ideas for the future well being of the industry.

IFPAC SCIENTIFIC BOARD

Co-Chairs
Scott Armstrong, ExxonMobil, Baton Rouge, LA
John Kauffman, FDA, CDER, OPS, OTR, DPA, St. Louis, MO
G.K. Raju, Light Pharma, Cambridge, MA
Martin Warman, Vertex Pharmaceuticals, Boston, MA

Members
Lucinda Buhse, FDA, CDER, OPS, OTR, DPA, St. Louis, MO
Sharmista Chatterjee FDA, CDER, OPS, ONDQA, Silver Spring, MD
James Cheney,Celgene, Summit, NJ
John Crandall,Falcon Analytical, Ronceverte, WV
Troy Francisco, DuPont Company, Wilmington DE
Rick Friedman, FDA, CDER, OMPQ, OC, OMPT, Silver Spring, MD
Steve Hammond Pfizer, Inc., Morris Plains, NJ
Walter Henslee, PhD, Dow Chemical Lead PAT Scientist, retired
Mel Koch APL, Univ. of Washington, Seattle, WA
Evdokia Korakianiti EMA
Theodora Kourti GlaxoSmithKline
Steve Kozlowski FDA, CDER, OPS, OBP, Silver Spring, MD
Mark A. LaPack Eli Lilly & Company, Indianapolis, IN
Lorenz Liesum, Novartis Pharma, Basel, Switzerland
Gawayne Maboubian-Jones Philip Morris International, Neuchatel, Switzerland
Matthew H. MacConnell, Air Products and Chemicals, Allentown, PA
Christine M. Moore FDA, CDER, ONDQA, OPS, Silver Spring, MD
Fernando Muzzio Rutgers University, New Brunswick, NJ
Moheb M. Nasr GSK
Manoharan Ramasamy, Merck & Co., Inc, West Point, PA
Brian Rohrback Infometrix, Inc., Bothell, WA
Tim Stevens, Bristol-Myers Squibb, New Brunswick, NJ
J.D. Tate Dow Chemical, Freeport, TX
Gert Thurau Hoffman-La Roche, Basil, Switzerland
Cenk Undey Amgen, Thousand Oaks, CA
Paul Vahey The Boeing Company, Boeing Research and Technology, Seattle, WA
Jeffrey W. Weber, Pfizer, Kalamazoo, MI

Representatives
Stephen Byrn CPPR/PTCC/CAMP, Purdue University, West Lafayette, IN
James Drennen III and Carl Anderson DCPT, Duquesne University, Pittsburgh, PA
Brian Marquardt Director, CPAC, APL, Univ. of Washington, Seattle, WA
Jose Cardoso de Menezes IST, UTL, Portugal
Fernando Muzzio Rutgers University, New Brunswick, NJ
Michael J. Tarlov NIST, Gaithersburg, MD

IFPAC Director
Robert S. Zutkis, IFPAC, Grayslake, IL